1. Supramolecular adducts of native and permethylated β-cyclodextrins with (2,2′-dipyridylamine)chlorido(1,4,7-trithiacyclononane)ruthenium(II) chloride: solid-state and biological activity studies
    Susana S. Braga et al, 2017, Chem. Pap. CrossRef
  2. Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.
    Atik Badshah Shaikh et al, 2016, Int J Mol Sci CrossRef
  3. Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
    Xiao-rong Yang et al, 2015, J Orthop Surg Res CrossRef
  4. Targeting protein kinases to reverse multidrug resistance in sarcoma
    Hua Chen et al, 2016, Cancer Treatment Reviews CrossRef
  5. Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
    Yu Mao et al, 2019, J Exp Clin Cancer Res CrossRef
  6. Anti-mitotic agents: Are they emerging molecules for cancer treatment?
    Larissa Siqueira Penna et al, 2017, Pharmacology & Therapeutics CrossRef
  7. Continuous treatment with FTS confers resistance to apoptosis and affects autophagy
    Eran Schmukler et al, 2017, PLoS ONE CrossRef
  8. Screening of Long Noncoding RNAs Induced by Radiation Using Microarray
    Yilong Wang et al, 2020, Dose-Response CrossRef
  9. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
    He Wang et al, 2015, Oncotarget CrossRef
  10. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays
    Hao Shen et al, 2018, Int J Mol Med CrossRef
  11. The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
    Isabella Syring et al, 2018, Oncol Lett CrossRef
  12. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
    Zuzanna Baranski et al, 2015, Genes Cancer CrossRef